activity Board of Medicine Directors
Scleroderma Foundation2018 - Presentactivity Composite responder Index for Scleroderma Trials Assessing Limited scleroderma
CRISTAL Index2021 - Presentactivity Arthritis Research and Therapy
2015 - Presentactivity Journal of Scleroderma
2015 - Presentactivity Yale Pulmonary Hypertension Steering Committee
2018 - Presentactivity 27. Role of intravenous epoprostenol in the treatment of threatened digital loss
activity 25. “Comparing Deep Neural Network Analysis to Modified Rodnan Skin Score in a Trial of Belumosudil for SSc Patients
activity 26. What’s new in the pathogenesis of interstitial lung disease (ILD)? Why are the lungs affected in SSc?
honor Top Doctor
activity Insights into the Pathogenesis of Systemic Sclerosis Interstitial Lung Disease”.
activity Deep Neural Network as a Systemic Sclerosis Outcome
activity The Scleroderma Esophagus
activity Molecular heterogeneity and personalized medicine in systemic sclerosis”.
activity Arthritis & Rheumatology
2020 - 2023activity Hearts and Hands in SSc
activity A Patient-Directed Research Program in Systemic Sclerosis
activity Beyond Skin in Systemic Sclerosis
activity AbbVie Fibrosis Group
AbbVie2021 - 2021activity Five new treatments for patients with systemic sclerosis
activity Department of Defense Systemic Sclerosis Stakeholders
Department of Defense Systemic SclerosisVirtual2020 - 2020